For more than a decade now, we have been publishing research and testimonials from people who have had success in reversing Alzheimer's Disease with coconut oil. The research and testimonials are published on CoconutOil.com, part of the Health Impact News network. During this same time period, we have seen the pharmaceutical industry fail over and over again to develop a drug that is effective in treating Alzheimer's Disease. Researchers in Australia are now studying coconut oil, and its unique composition of medium chain fatty acids, as a way to prevent and treat Alzheimer's Disease. Starting from the basis that Alzheimer's Disease is a form of diabetes, referred to in the past as a "Type 3" form of diabetes, or what the Australian researchers refer to as "brain glucose hypometabolism," the research focuses on providing an alternative form of energy to the brain in the form of "ketone bodies." The title of their study is: Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease, published in the March 2020 edition of the journal Mechanisms of Ageing and Development. It is an exhaustive look at the current literature on this topic, with hundreds of references.
Coconut oil, whose health benefits have been proven in the past, will be tested for use as a potential treatment for the novel coronavirus infection. “That [VCO] is being looked into,” Philippine Health Secretary Francisco Duque III told CNN Philippines’ Newsroom on Tuesday. “We have heard very good studies with regard to its ability to neutralize the viruses, but for the COVID- 19, it is not clear,” the top health official added. He made the reaction following Cabinet Secretary Karlo Nograles' announcement Monday that a former academician from one of the country’s top universities proposed to test coconut oil as COVID-19 treatment amid the absence of a specific treatment. In a research proposal published on January 31, Ateneo de Manila University Professor Emeritus Fabian Antonio Dayrit and Dr. Mary Newport of Spring Hill Neonatolody in Florida, United States proposed to conduct a clinical study on patients infected with the COVID-19 involving VCO, saying “this treatment is affordable and virtually risk-free, and the potential benefits are enormous.” Nograles said the National University of Singapore has agreed to test VCO as a prophylactic against the COVID-19. Current evidence suggests coconut oil and its derivatives are safe and effective antiviral compounds in both humans and animals, the researchers noted. “Several in vitro, animal, and human studies support the potential of coconut oil, lauric acid and its derivatives as effective and safe agents against a virus like nCoV-2019 [COVID-19],” they said.
People living in the Philippines, a country of islands not very far off the coast of China, remember all too well the last time a deadly coronavirus epidemic broke out in China. It was 2003 when the SARS (severe acute respiratory syndrome) coronavirus broke out in China. It infected over 7000 people in China with over 600 recorded deaths. Even with its close proximity to China and large Chinese population in the Philippine nation of about 80 million people, only 14 cases of SARS was reported with two recorded deaths. Canada, many thousands of miles away, had far more cases and more deaths recorded due to SARS infection from China than neighboring Philippine Islands. One of the theories put forward at the time as to why the Filipino people had so few cases, was the country's predominant use of cooking oil: Coconut Oil. The Philippines is the world's largest producer of coconut oil, with about 70% of the world's coconut oil being exported from the country. The medium chain fatty acids of coconut oil, and primarily lauric acid, have been known to destroy enveloped viruses by researchers for many years. Dr. Fabian Dayrit, Ph.D. and Dr. Mary Newport, M.D. have just published a paper regarding coconut oil's potential to also combat the new coronavirus currently infecting people in China.
New Research on Coconut Oil Focuses on Replacing Antibiotics to Combat Antibiotic-resistant Pathogens
Coconut oil is nature's richest source of lauric acid, long known to be a powerful antimicrobial. As a saturated fat, coconut oil is almost 50% lauric acid. Nature's next most abundant source of lauric acid, human breast milk, comes in a distant second. For years now, research (primarily outside of the U.S.) on coconut oil has focused on the use of lauric acid as an adjunct or replacement for antibiotic drugs that have lost their effectiveness due to the emergence of antibiotic-resistant pathogens. 2019 has seen more studies published where coconut oil is studied in this context: how to deal with the emergence of antibiotic resistant pathogens, and the decreasing effectiveness of antibiotic drugs. A Japanese study published in the journal Cell Transplant was especially promising, as it showed that lauric acid could potentially be used as a broad spectrum anti-microbiological agent without disrupting the "good bacteria" in the human gut microbiota.
Study: Lauric Acid from Coconut Oil Proves a Promising Weapon in the Fight Against Antibiotic Resistant Infection with Severe Burns
Lauric acid, found predominately in coconut oil, may be a powerful tool in the prevention of infection and promote wound regeneration in severe burn patients, according to a recent study. Along with research that has previously shown the effectiveness of the use of lauric acid in combatting barrier-disrupting issues, the future for the use of saturated fatty acid in inhibiting infectious Gram-positive microbial bacteria and in skin barrier restoration is promising. A mere thirty years ago patients who had sustained burns over 50% of their body were given little to no hope of survival, a history which stands in stark contrast to the current status where people who have sustained burns covering even ninety percent of their bodies are now capable of recovery, albeit often with serious disabilities. The increase in survival rates is directly related to the advances made in specialized burn care by the medical community, with better fluid resuscitation, nutritional support, pulmonary care, wound care and infection control playing critical roles. Still, in patients whose burns cover over 40% of the entire body, approximately seventy-five percent of deaths are largely attributable to sepsis from infected wounds or complications derived from infection. Because the damaged tissue, which in its healthy state would act as a protective barrier, is seriously compromised in burn victims, topical antibiotics are necessary in keeping the moist wounds from becoming hotbeds of infection. The increase in antibiotic-resistant bacteria strains is creating a necessity for researchers to identify substances that are both antibacterial and regenerative. Lauric acid, with its anti-viral and anti-microbial properties, is one such substance that researchers are hopeful may fit the above criteria perfectly.
With Chronic Kidney Disease (CKD) on the rise, and its clear relationship to unmanaged blood sugar and blood pressure unquestioned, virgin coconut oil is proving a valuable addition to the fight with ameliorate kidney function parameters in suffers of CKD and can even be protective for those at risk for the disease. Lowering your risk for kidney dysfunction rests largely on lifestyle changes, but for change to occur in something so entrenched as an individual’s lifestyle, there is a need for impetus, and despite the fact that over 37 million people in the US alone are estimated to have CKD, many of those are completely unaware of the slippery slope they are currently on or headed towards. It’s interesting that virgin coconut oil, which is often a prominent part of a healthy ketogenic diet, also shows promise in studies as a potential therapy in the treatment and prevention of kidney dysfunction. Perhaps the only thing standing in the way of discovering the full benefits of virgin coconut oil in the treatment of chronic kidney disease and fully embracing it, is our society's ingrained acceptance of long held and poorly supported nutritional doctrine. Luckily in the cases of kidney function and diabetes, science is confirming that there is hope to be found in change… and that a couple of tablespoons of virgin coconut oil consumed daily may be just the place to start.
The Health Benefits of Topical Virgin Coconut Oil for Preterm Infants – Studies Show Why You want to Massage Your Newborn Baby with Coconut Oil
Most of us who have reached maturity take our body's largest organ at face value, spending a staggering $300 billion on anti-aging globally and approximately $400 million U.S. dollars yearly on over-the counter acne solutions to put on a pretty face. But for the newest and most vulnerable among us, preterm and full-term infants, healthy skin is critical to their very survival, and here is where researchers think virgin coconut oil may be a major contributor in the fight to lower preterm infant mortality. Complications arising from preterm births are the leading cause of death globally for children under the age of five, according to the World Health Organization.
Repatha is a new cholesterol-lowering medication that works differently from statins. It is part of an expensive class of medications that currently costs about $14,000 per year. When Repatha first came out I predicted that this class of drugs would (similarly to statins) fail and, furthermore, cause too many adverse effects. When we reviewed the article, we concluded Repatha was not very effective as it failed to help nearly 98% who took it. As we were about to finish our discussion, I said let’s look at the adverse effects from this drug. Adverse side effects were encountered by 77.4% of those treated with both Repatha and the placebo. As for serious side effects, 24.8% of the Repatha group and 24.7% of the placebo group suffered a serious adverse effect. We were both stunned. How could a therapy have such a high rate of adverse effects, especially serious adverse effects? And, how could a placebo have such a high rate of adverse and serious adverse events?
Study: Coconut Oil a Healthy Saturated Fat – But the FDA Prohibits the use of “Healthy” in Describing Coconut Oil
Recently we covered a study published in the journal Clinical Nutrition which compared peanut oil consumption with coconut oil consumption among healthy men in India, where those who consumed coconut oil had better health outcomes in terms of heart disease and diabetes. (See: Coconut oil consumption improves fat-free mass, plasma HDL-cholesterol and insulin sensitivity in healthy men with normal BMI compared to peanut oil.) A researcher at The University of Edinburgh Medical School wrote a Letter to the Editor of Clinical Nutrition commenting on this study, criticizing current government nutritional guidelines regarding saturated dietary fat restrictions. "The cross-over study by Korrapati et al. detailed the potential cardioprotective effect of coconut oil, and I would like to thank the authors for their insight. Whilst the sample size was small, it was well-designed to investigate its primary end-points. This study is particularly topical as, despite removal of the maximum dietary fat intake restriction from guidelines, a major resistance against saturated fats remains." Setting aside the issue of whether or not saturated fats should be restricted at all, given the abundance of contrary evidence in the medical literature, the Edinburgh Medical School researcher reported that such guidelines do not distinguish between different types of saturated fats. Saturated fats can be found in animal products, such as butter, as well as plant sources, such as coconuts and date palms. "The rise in high density lipoprotein cholesterol (HDL-c) with coconut oil consumption is certainly a compelling finding. Results from a recent and larger-scale randomised trial by Khaw et al. corroborate this... Evidence suggests that the saturated versus unsaturated distinction of fats is likely an oversimplification. Korrapati et al. should, therefore, be commended on their focus on the biological properties of coconut oil, particularly the medium chain triglyceride (MCT) dominated fatty acid profile, which may confer atheroprotective effects."
Want to flip a coin on your health? Researchers assessing the effectiveness of cholesterol-lowering statin drugs found that they didn’t work for 51% of the 165,000 patients studied (statins have to reduce LDL cholesterol levels by 40% after two years to be considered effective). We’ve reported previously about the many side effects and dangers of taking statins. We’ve also pointed out that conventional thinking supporting statins—lowering “bad” LDL cholesterol as a means of preventing cardiovascular disease—is outdated. With one in four Americans over the age of 40 taking a statin, there are a lot of people out there spending money on a dangerous drug that is not providing any benefit. Will doctors change their prescribing practices based on this information? It doesn’t seem so. Statins make tens of billions of dollars a year for the drug industry, and the market is growing. Statin use among adults over the age of 40 increased almost 80% between 2002 and 2013.